Working the night shift can wreak havoc on your health in just a few days, a study from Washington State University reveals.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

a diabetes researcher at the University of Melbourne. The next generation of drugs will target specific conditions associated with diabetes and obesity, such as sleep apnoea, fatty liver disease, ...

As the prevalence of overweight and obesity increases, health and welfare costs will also increase substantially. 4 The financial consequences for the individual and the healthcare system will ...